SCHEMBL21701924

SCHEMBL21701924

N#Cc1cccc(-c2ccc3c(c2)-c2cc(-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)ccc2C32c3ccccc3Sc3ccccc32)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 1/20 0.42
PDK2 Q15119 1/20 0.42
GABRA1 P14867 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
CYP1A2 P05177 6/20 0.41
MEN1 O00255 6/20 0.41
ALDH1A1 P00352 6/20 0.41
KMT2A Q03164 6/20 0.41
LMNA P02545 5/20 0.41
HSD17B10 Q99714 3/20 0.41
MAPT P10636 3/20 0.41
TSHR P16473 2/20 0.41
KDM4E B2RXH2 2/20 0.41
TP53 P04637 2/20 0.41
ADORA2A P29274 3/20 0.40
ADORA1 P30542 2/20 0.40
ADORA3 P0DMS8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21702227 0.96 ALDH1A3 (0.41) ALDH1A3PDK2GABRA1GABRG2GABRB3
SCHEMBL21701867 0.95 ABCG2 (0.38) ALDH1A3PDK2GABRA1GABRG2GABRB3
SCHEMBL21701876 0.94 CYP1A2 (0.43) ALDH1A3PDK2GABRA1GABRG2GABRB3
SCHEMBL21702229 0.93 MEN1 (0.38) ALDH1A3PDK2GABRA1GABRG2GABRB3
SCHEMBL21702225 0.93 ABCG2 (0.41) ALDH1A3PDK2GABRA1GABRG2GABRB3
SCHEMBL21701878 0.93 CYP1A2 (0.42) ALDH1A3PDK2GABRA1GABRG2GABRB3
SCHEMBL21701618 0.93 ABCG2 (0.42) ALDH1A3PDK2GABRA1GABRG2GABRB3
SCHEMBL21701865 0.92 ABCG2 (0.40) ALDH1A3PDK2GABRA1GABRG2GABRB3
SCHEMBL21701864 0.92 ABCG2 (0.41) ALDH1A3PDK2GABRA1GABRG2GABRB3
SCHEMBL23256718 0.91 PDK2 (0.39) ALDH1A3PDK2GABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME CRY1, CRY2, CYP1A1 ALDH1A3 249/4885PDK2 1415/4885GABRA1 1921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.